Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
ARA-290 (cibinetide) is an 11 amino acid non-erythropoietic peptide derived from erythropoietin's helix-B domain. It selectively activates the innate repair receptor (IRR), an EPOR/CD131 heterodimer, to promote anti-inflammatory and tissue-protective effects without stimulating red blood cell production. Clinical trials have demonstrated benefits for diabetic neuropathy and sarcoidosis-related small-fiber neuropathy.
This product is intended strictly for laboratory research purposes only. It is not approved for human or animal use and must not be used in food, supplements, pharmaceuticals, or cosmetic applications.
ARA-290 (cibinetide) is an 11 amino acid non-erythropoietic peptide derived from erythropoietin's helix-B domain. It selectively activates the innate repair receptor (IRR), an EPOR/CD131 heterodimer, to promote anti-inflammatory and tissue-protective effects without stimulating red blood cell production. Clinical trials have demonstrated benefits for diabetic neuropathy and sarcoidosis-related small-fiber neuropathy.
This product is intended strictly for laboratory research purposes only. It is not approved for human or animal use and must not be used in food, supplements, pharmaceuticals, or cosmetic applications.
Access is restricted to individuals 21 years of age or older.
